SCHEMBL8375718

SCHEMBL8375718

COC(=O)C(C(=O)c1ccccc1)C1CC1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.49
KMT2A Q03164 4/20 0.48
ALDH1A1 P00352 3/20 0.44
NPSR1 Q6W5P4 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.43
MEN1 O00255 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
PTGS1 P23219 1/20 0.41
PTGS2 P35354 1/20 0.41
KDM4E B2RXH2 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
THRB P10828 1/20 0.41
SLC6A3 Q01959 4/20 0.40
SLC6A2 P23975 1/20 0.40
SLC6A4 P31645 1/20 0.40
DHFR P00374 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28077720 0.94 TSHR (0.57) TSHRKMT2AALDH1A1NPSR1SMN1; SMN2
SCHEMBL16050429 0.78 TSHR (0.60) TSHRKMT2AALDH1A1NPSR1SMN1; SMN2
SCHEMBL28077872 0.78 TSHR (0.64) TSHRKMT2AALDH1A1NPSR1SMN1; SMN2
SCHEMBL4097632 0.77 PLK1 (0.46) TSHRKMT2AMEN1
SCHEMBL14014030 0.77 SMN1; SMN2 (0.50) TSHRKMT2AALDH1A1NPSR1SMN1; SMN2
SCHEMBL14257280 0.77 SMN1; SMN2 (0.50) TSHRKMT2AALDH1A1NPSR1SMN1; SMN2
SCHEMBL4710089 0.77 SMN1; SMN2 (0.53) KMT2AALDH1A1NPSR1SMN1; SMN2KDM4E
SCHEMBL27926754 0.75 THRB (0.55) TSHRKMT2AALDH1A1NPSR1SMN1; SMN2
SCHEMBL5706065 0.75 KMT2A (0.51) TSHRKMT2AALDH1A1PTGS1PTGS2
SCHEMBL2097359 0.74 KMT2A (0.55) TSHRKMT2AALDH1A1PTGS1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6005116-A HAVE INHIBITION ACTIVITIES AGAINST TYPE A-MONOAMINE OXIDASE; TREATING OR PREVENTING DEPRESSION, PARKINSON'S DISEASE, ALZEHEIMER'S DEMENTIA, OR CEREBROVASCULAR DEMENTIA SANKYO COMPANY, LIMITED (JP) 1999-12-21 US disclosed
EP-0885891-A1 ISOXAZOLE DERIVATIVES SANKYO COMPANY LIMITED (JP) 1998-12-23 EP disclosed